UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P-45 LIVER HEMODYNAMIC AND TRANSJUGULAR LIVER BIOPSY: ROLE IN DIAGNOSTIC AND THERAPEUTIC BEHAVIOR

Annals of hepatology, 2021-09, Vol.24, p.100409, Article 100409

2021

Volltextzugriff (PDF)

Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease

Frontiers in pharmacology, 2021-09, Vol.12, p.729950-729950

2021

Volltextzugriff (PDF)

Acute liver failure due to herpes simplex virus: diagnostic clues and potential role of plasmapheresis: A case report

Medicine (Baltimore), 2021-09, Vol.100 (35), p.e27139-e27139

2021

Volltextzugriff (PDF)

Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients

Canadian journal of gastroenterology & hepatology, 2022, Vol.2022, p.1-9

2022

Volltextzugriff (PDF)

P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION

Annals of hepatology, 2021-09, Vol.24, p.100404, Article 100404

2021

Volltextzugriff (PDF)

Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4387

2024

Volltextzugriff (PDF)

O-30 ALCOHOL-HARM PARADOX IN LATIN AMERICA: HOW TO STUDY IT DESPITE DATA LIMITATIONS? THE CHILEAN EXPERIENCE

Annals of hepatology, 2023-03, Vol.28, p.101037, Article 101037

2023

Volltextzugriff (PDF)

The immune response as a therapeutic target in non-alcoholic fatty liver disease

Frontiers in immunology, 2022-10, Vol.13, p.954869-954869

2022

Volltextzugriff (PDF)

Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis

Annals of hepatology, 2024-07, Vol.29 (4), p.101511, Article 101511

2024

Volltextzugriff (PDF)

P-126 INTERPHASE HEPATITIS IN PRIMARY BILIARY CHOLANGITIS, SEVERITY FACTOR AND NO RESPONSE TO URSODEOXICOLIC ACID?

Annals of hepatology, 2021-09, Vol.24, p.100486, Article 100486

2021

Volltextzugriff (PDF)

P-62 INFECTIONS IN THE FIRST MONTH POST LIVER TRANSPLANTATION IN A TRANSPLANT CENTER IN CHILE

Annals of hepatology, 2021-09, Vol.24, p.100425, Article 100425

2021

Volltextzugriff (PDF)

P-41 TRENDS IN HOSPITALIZATION, CHARACTERISTICS AND MORTALITY OF HOSPITALIZED PATIENTS WITH CIRRHOSIS IN CHILE

Annals of hepatology, 2021-09, Vol.24, p.100405, Article 100405

2021

Volltextzugriff (PDF)

Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease

Free radical biology & medicine, 2004-11, Vol.37 (9), p.1499-1507

2004

Volltextzugriff (PDF)

Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease

Trends in molecular medicine, 2006-12, Vol.12 (12), p.555-558

2006

Volltextzugriff (PDF)

Small Intestinal Clustered Contractions and Bacterial Overgrowth: A Frequent Finding in Obese Patients

Digestive diseases and sciences, 2011-01, Vol.56 (1), p.155-160

2011

Volltextzugriff (PDF)

P- 90 EFFECT OF THE DELIVERY OF WRITTEN INFORMATION ON DISEASE-RELATED KNOWLEDGE IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED FACTORS

Annals of hepatology, 2023-03, Vol.28, p.100981, Article 100981

2023

Volltextzugriff (PDF)

O-14 NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY HEART DISEASE

Annals of hepatology, 2023-03, Vol.28, p.101024, Article 101024

2023

Volltextzugriff (PDF)

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

Clinical science (1979), 2004-03, Vol.106 (3), p.261-268

2004

Volltextzugriff (PDF)

P-65 CONCORDANCE OF FIB-4 WITH TRANSITION ELASTOGRAPHY IN THE DIAGNOSIS OF ADVANCED LIVER FIBROSIS

Annals of hepatology, 2021-09, Vol.24, p.100428, Article 100428

2021

Volltextzugriff (PDF)

P-63 TRENDS IN HOSPITALIZATION AND MORTALITY IN HOSPITALIZED PATIENTS WITH ALCOHOLIC HEPATITIS IN CHILE

Annals of hepatology, 2021-09, Vol.24, p.100426, Article 100426

2021

Volltextzugriff (PDF)

P-59 LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE IN A UNIVERSITY HOSPITAL OF CHILE

Annals of hepatology, 2021-09, Vol.24, p.100423, Article 100423

2021

Volltextzugriff (PDF)

P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS

Annals of hepatology, 2021-09, Vol.24, p.100422, Article 100422

2021

Volltextzugriff (PDF)

P-44 TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH CONTROVERSIAL INDICATION

Annals of hepatology, 2021-09, Vol.24, p.100408, Article 100408

2021

Volltextzugriff (PDF)

P-56 LOW ROLE OF NON-INVASIVE FIBROSIS ASSESSMENT USING FIB-4 AND APRI IN PATIENTS WITH AUTOIMMUNE HEPATITIS

Annals of hepatology, 2021-09, Vol.24, p.100420, Article 100420

2021

Volltextzugriff (PDF)

P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA

Annals of hepatology, 2021-09, Vol.24, p.100407, Article 100407

2021

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(203)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P-45 LIVER HEMODYNAMIC AND TRANSJUGULAR LIVER BIOPSY: ROLE IN DIAGNOSTIC AND THERAPEUTIC BEHAVIOR

Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease

Acute liver failure due to herpes simplex virus: diagnostic clues and potential role of plasmapheresis: A case report

Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients

P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION

Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

O-30 ALCOHOL-HARM PARADOX IN LATIN AMERICA: HOW TO STUDY IT DESPITE DATA LIMITATIONS? THE CHILEAN EXPERIENCE

The immune response as a therapeutic target in non-alcoholic fatty liver disease

Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis

P-126 INTERPHASE HEPATITIS IN PRIMARY BILIARY CHOLANGITIS, SEVERITY FACTOR AND NO RESPONSE TO URSODEOXICOLIC ACID?

P-62 INFECTIONS IN THE FIRST MONTH POST LIVER TRANSPLANTATION IN A TRANSPLANT CENTER IN CHILE

P-41 TRENDS IN HOSPITALIZATION, CHARACTERISTICS AND MORTALITY OF HOSPITALIZED PATIENTS WITH CIRRHOSIS IN CHILE

Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease

Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease

Small Intestinal Clustered Contractions and Bacterial Overgrowth: A Frequent Finding in Obese Patients

P- 90 EFFECT OF THE DELIVERY OF WRITTEN INFORMATION ON DISEASE-RELATED KNOWLEDGE IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED FACTORS

O-14 NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY HEART DISEASE

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

P-65 CONCORDANCE OF FIB-4 WITH TRANSITION ELASTOGRAPHY IN THE DIAGNOSIS OF ADVANCED LIVER FIBROSIS

P-63 TRENDS IN HOSPITALIZATION AND MORTALITY IN HOSPITALIZED PATIENTS WITH ALCOHOLIC HEPATITIS IN CHILE

P-59 LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE IN A UNIVERSITY HOSPITAL OF CHILE

P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS

P-44 TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH CONTROVERSIAL INDICATION

P-56 LOW ROLE OF NON-INVASIVE FIBROSIS ASSESSMENT USING FIB-4 AND APRI IN PATIENTS WITH AUTOIMMUNE HEPATITIS

P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA

Suchergebnisse filtern